- July 31, 2025
Obesity drugs gain weight in labs: Several clinical trials by big and small pharma cos underway
-
- by Vikas Dandekar and Tanishka Dubey
- July 31, 2025
- in technology
Mumbai: As blockbuster weight-loss drugs Wegovy (semaglutide) and Mounjaro (tirzepatide) reap billions of dollars on hysteric demand for innovators Novo Nordisk and Eli Lilly, more pharma companies b… [+4236 chars] Show more...
Driven by the success of Wegovy and Mounjaro, numerous pharma companies are developing anti-obesity drugs, with over 170 in various stages. While giants like Novartis and GSK are cautious, Eli Lilly and Novo Nordisk lead the race. Research expands beyond GLP-…
you may also like
- LUMINOX MIL-SPEC WATCH
- July 31, 2025
LUMINOX MIL-SPEC WATCH
- Vikas Dandekar and Tanishka Dubey
- July 31, 2025
0 Comments:
Leave a Reply